IL120924A - Transformed Neptoylguanidines, Process for Preparation and Pharmaceuticals or Diagnostic Containers Containing Them - Google Patents

Transformed Neptoylguanidines, Process for Preparation and Pharmaceuticals or Diagnostic Containers Containing Them

Info

Publication number
IL120924A
IL120924A IL12092497A IL12092497A IL120924A IL 120924 A IL120924 A IL 120924A IL 12092497 A IL12092497 A IL 12092497A IL 12092497 A IL12092497 A IL 12092497A IL 120924 A IL120924 A IL 120924A
Authority
IL
Israel
Prior art keywords
carbon atoms
alkyl
independently
another
group
Prior art date
Application number
IL12092497A
Other languages
English (en)
Hebrew (he)
Other versions
IL120924A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL120924A0 publication Critical patent/IL120924A0/xx
Publication of IL120924A publication Critical patent/IL120924A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Surgery (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
IL12092497A 1996-05-29 1997-05-27 Transformed Neptoylguanidines, Process for Preparation and Pharmaceuticals or Diagnostic Containers Containing Them IL120924A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19621483A DE19621483A1 (de) 1996-05-29 1996-05-29 Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (2)

Publication Number Publication Date
IL120924A0 IL120924A0 (en) 1997-09-30
IL120924A true IL120924A (en) 2002-03-10

Family

ID=7795549

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12092497A IL120924A (en) 1996-05-29 1997-05-27 Transformed Neptoylguanidines, Process for Preparation and Pharmaceuticals or Diagnostic Containers Containing Them

Country Status (29)

Country Link
US (1) US6087304A (el)
EP (1) EP0810206B1 (el)
JP (1) JP4039588B2 (el)
KR (1) KR970074776A (el)
CN (1) CN1167759A (el)
AR (1) AR008373A1 (el)
AT (1) ATE198320T1 (el)
AU (1) AU710065B2 (el)
BR (1) BR9703338A (el)
CA (1) CA2206366C (el)
CZ (1) CZ163097A3 (el)
DE (2) DE19621483A1 (el)
DK (1) DK0810206T3 (el)
ES (1) ES2154002T3 (el)
GR (1) GR3035126T3 (el)
HR (1) HRP970292B1 (el)
HU (1) HUP9700955A3 (el)
ID (1) ID16989A (el)
IL (1) IL120924A (el)
NO (1) NO308527B1 (el)
NZ (1) NZ314915A (el)
PL (1) PL185754B1 (el)
PT (1) PT810206E (el)
RU (1) RU2190600C2 (el)
SI (1) SI0810206T1 (el)
SK (1) SK282020B6 (el)
TR (1) TR199700428A2 (el)
TW (1) TW416944B (el)
ZA (1) ZA974665B (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19621482A1 (de) 1996-05-29 1997-12-04 Hoechst Ag Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US6395897B1 (en) 1999-03-02 2002-05-28 Boehringer Ingelheim Pharmaceuticals, Inc. Nitrile compounds useful as reversible inhibitors of #9 cathepsin 5
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
PE20040167A1 (es) * 2002-03-28 2004-05-26 Novartis Ag Amidas del acido sulfamico
PL1755593T3 (pl) * 2004-06-02 2008-06-30 Hoffmann La Roche Pochodne naftalenu przydatne jako ligandy 3-receptora histaminowego
TW200614995A (en) * 2004-11-10 2006-05-16 Nicholas Piramal India Ltd Tricyclic guanidine derivatives as sodium-proton exchange inhibitors
AU2013205388B2 (en) * 2005-06-24 2016-05-05 Biotron Limited Antiviral compounds and methods
PL2826770T3 (pl) 2005-06-24 2019-02-28 Biotron Limited Przeciwwirusowe związki acyloguanidynowe
DE602007008742D1 (de) * 2006-09-15 2010-10-07 Pfizer Substituierte pyridylmethylbicyclocarboxyamidverbindungen
JPWO2010090304A1 (ja) * 2009-02-09 2012-08-09 アステラス製薬株式会社 アシルグアニジン誘導体
JPWO2010090305A1 (ja) * 2009-02-09 2012-08-09 アステラス製薬株式会社 置換アシルグアニジン誘導体
TW201116281A (en) * 2009-08-06 2011-05-16 Astellas Pharma Inc N atom containing ring acylguanidine derivatives
KR20140003484A (ko) 2011-02-02 2014-01-09 아스테라스 세이야쿠 가부시키가이샤 테트라히드로이소퀴놀린 유도체

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251545A (en) * 1979-09-19 1981-02-17 Gaf Corporation Fungicidal process using 1-(alkoxyaroyl)guanidines
IT1238227B (it) * 1989-12-01 1993-07-12 Modulo di smistamento per impianti di convogliamento a nastro e simili
DE4035961A1 (de) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4415873A1 (de) * 1994-05-05 1995-11-09 Hoechst Ag Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
JPH08225513A (ja) * 1994-12-21 1996-09-03 Kanebo Ltd ナフトイルグアニジン誘導体
DE19621482A1 (de) * 1996-05-29 1997-12-04 Hoechst Ag Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
PL185754B1 (pl) 2003-07-31
BR9703338A (pt) 1998-08-18
DE19621483A1 (de) 1997-12-04
ATE198320T1 (de) 2001-01-15
US6087304A (en) 2000-07-11
NO972433D0 (no) 1997-05-28
ZA974665B (en) 1997-12-01
DE59702802D1 (de) 2001-02-01
SI0810206T1 (en) 2001-04-30
HUP9700955A3 (en) 1998-04-28
PT810206E (pt) 2001-06-29
TW416944B (en) 2001-01-01
NO308527B1 (no) 2000-09-25
HUP9700955A2 (hu) 1998-03-02
HU9700955D0 (en) 1997-07-28
SK282020B6 (sk) 2001-10-08
AU710065B2 (en) 1999-09-16
JP4039588B2 (ja) 2008-01-30
CA2206366A1 (en) 1997-11-29
AR008373A1 (es) 2000-01-19
ES2154002T3 (es) 2001-03-16
AU2364597A (en) 1997-12-04
JPH1081664A (ja) 1998-03-31
GR3035126T3 (en) 2001-03-30
ID16989A (id) 1997-11-27
HRP970292A2 (en) 1998-04-30
RU2190600C2 (ru) 2002-10-10
KR970074776A (ko) 1997-12-10
EP0810206B1 (de) 2000-12-27
PL318723A1 (en) 1997-12-08
NO972433L (no) 1997-12-01
SK67097A3 (en) 1997-12-10
NZ314915A (en) 1998-02-26
IL120924A0 (en) 1997-09-30
HRP970292B1 (en) 2001-08-31
MX9703922A (es) 1997-11-29
DK0810206T3 (da) 2001-02-26
CZ163097A3 (cs) 1998-06-17
CN1167759A (zh) 1997-12-17
CA2206366C (en) 2008-02-19
TR199700428A2 (xx) 1997-12-21
EP0810206A1 (de) 1997-12-03

Similar Documents

Publication Publication Date Title
AU713664B2 (en) Phenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
US5965744A (en) Ortho-substituted benzoylguanidines, including composition and methods of using them
KR100376194B1 (ko) 퍼플로우로알킬치환된벤조일구아니딘,이의제조방법및이를함유하는약제학적조성물
US5719169A (en) Substituted benzoylguanidines, their use as a medicament or diagnostic, and medicament containing them
MXPA97006380A (en) Guarides of alkenil-carboxylic acids replaced with phenyl, procedures for preparation, use as a medicine or diagnostic agent, as well as a medication that contains them
CA2206366C (en) Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
US5880156A (en) Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them
PL179395B1 (pl) kwasów alkenylokarboksylowych, sposób ich wytwarzaniaoraz srodek leczniczy zawierajacy fenylopodstawione guanidydy kwasów alkenylokarboksylowych zawierajace grupy perfluoroalkilowe PL PL PL PL
US5883133A (en) Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents and medicaments comprising them
US5665739A (en) Substituted benzoylguanidines, process and their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
AU710258B2 (en) Substituted 1-naphthoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament containing them
RU2161604C2 (ru) Замещенные основанием бензоилгуанидины, способ их получения, фармацевтический состав, способ его получения и способ ингибирования клеточного na+/h+-антипортера
US5731350A (en) Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
MXPA97003922A (en) 2-naftoilguanidinas substituted, procedure for preparation, its employment as a diagnostic occasive drug, as well as a medicinal product chelas conti
MXPA97003921A (en) 1-naftoilguanidinas substitute, procedure for its preparation, its employment as a medicine or diagnostic agent, as well as a medication that the

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees